COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,612,061 | +32.1% | 50,064 | +59.3% | 0.00% | – |
| Q1 2024 | $1,219,879 | +216.5% | 31,424 | +151.0% | 0.00% | – |
| Q4 2023 | $385,396 | +49.9% | 12,521 | +8.8% | 0.00% | – |
| Q3 2023 | $257,160 | -53.7% | 11,506 | -55.5% | 0.00% | – |
| Q2 2023 | $555,709 | -29.9% | 25,859 | -21.7% | 0.00% | – |
| Q1 2023 | $792,245 | +78.8% | 33,024 | +32.1% | 0.00% | – |
| Q2 2022 | $443,000 | +14.8% | 25,006 | +35.0% | 0.00% | – |
| Q3 2020 | $386,000 | – | 18,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |